Mundipharma
Lara Muller is an experienced compliance professional currently serving as the Senior Compliance Officer for Southern Europe and Brazil at Mundipharma since October 2020, with interim roles focused on Italy, Spain, and Portugal and as the Global Third Party Management Lead. Previously, Lara held the position of Risk and Compliance Manager at Diageo, and served as Regional Compliance Officer and Global Compliance Coordinator at Coty. Initial experience includes a role as Paralegal Compliance Executive at British American Tobacco and Support Lawyer at Linklaters. Lara's early legal career featured representation in various court settings and familiarity with civil litigation and contract assistance at multiple law firms in Brazil. Lara holds a Diploma in Anti Money Laundering from the International Compliance Association, a Master's in International Commercial Law from the University of Nottingham, and a Bachelor’s in Law from UEL - Universidade Estadual de Londrina.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.